Mohar A, Reynoso N, Villarreal-Garza C, Bargalló-Rocha JE, Arce-Salinas C, Lara-Medina F

Language: Spanish
References: 8
Page: 6-11
PDF size: 327.96 Kb.

ABSTRACT

In 2003, Mexico embarked on a structural reform to improve the health system performance by establishing the System of Social Protection in Health. The main innovation has been the Seguro Popular. In this work, we review the experience of breast cancer at the Instituto Nacional de Cancerología (INCan), whose costs were covered by the Seguro Popular. Methods: A retrospective analysis was performed on this group of patients who received medical treatment at the INCan from 2007 to 2013. This analysis included demographic, diagnostic, clinical and survival data. Results: A total of 3,109 cases was reviewed. The median age was 50 years; 70% were diagnosed in clinical stage IIA and higher; 80% required multidisciplinary treatment; 22% had over expression of HER2; and 17% were triple negative. The overall survival was comparable to that observed in other populations, according to clinical stage and immunophenotype. Conclusion: The clinical experience of the INCan showed excellent results in the control of this disease, with excellent follow-up. However, it is essential to improve the primary and secondary prevention programs for breast cancer in Mexico, due to the high personal and economic costs that this public health problem yields to our country.

REFERENCES

1. Knaul FM, González-Pier E, Gómez-Dantés O et al. The quest for universal health coverage: achieving social protection for all in Mexico. The Lancet. 2012; 380: 1259-1279.

2. Frenk J, Gonzalez Pier E, Gómez-Dantés O, Lezana MA, Kna­ul F. Reforma integral para mejorar el desempeño del sistema de salud en México. Salud Pública Mex. 2007; 49 (Supl I): S23-S36.

3. Frenk J. Tender puentes: lecciones globales desde México sobre políticas de salud basadas en evidencias. Salud Pública Mex. 2007; 49 (Suppl 1): S14-S22.

4. Mohar A, Bargalló E, Ramírez MT, Lara F Beltrán-Ortega A. Recursos disponibles para el tratamiento del cáncer de mama en México. Salud Pública Méx. 2009; 51 (Supl 2): 263-269.

5. Justo N, Wilking N, Jönsson B, Luciani S, Cazap E. A review of breast cancer care and outcomes in Latin America. Oncologist. 2013; 18: 248-256.

6. Villarreal-Garza C, Aguila C, Magallanes-Hoyos MC, Mohar A, Bargalló E, Meneses A et al. Breast cancer in young women in Latin America: an unmet, growing burden. Oncologist. 2013; 18 Suppl: 26-34.

7. Cazap E, Distelhorst SR, Anderson BO. Implementation science and breast cancer control: a Breast Health Global Initiative (BHGI) perspective from the 2010 Global Summit. Breast. 2011; Suppl 2: S1-S2.

8. Lara-Medina F, Pérez-Sánchez V, Saavedra-Pérez D, Blake-Cerda M, Arce C, Motola-Kuba D et al. Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer. 2011; 117: 3658-3669.